Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Yang P, Kanki H, Drolet B, Yang T, Wei J, Viswanathan PC, Hohnloser SH, Shimizu W, Schwartz PJ, Stanton M, Murray KT, Norris K, George AL, Roden DM (2002) Circulation 105: 1943-8 Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. Lee MP, Ravenel JD, Hu RJ, Lustig LR, Tomaselli G, Berger RD, Brandenburg SA, Litzi TJ, Bunton TE, Limb C, Francis H, Gorelikow M, Gu H, Washington K, Argani P, Goldenring JR, Coffey RJ, Feinberg AP (2000) J Clin Invest 106: 1447-55 Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. Lee MP, DeBaun M, Randhawa G, Reichard BA, Elledge SJ, Feinberg AP (1997) Am J Hum Genet 61: 304-9 Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting. Lee MP, DeBaun MR, Mitsuya K, Galonek HL, Brandenburg S, Oshimura M, Feinberg AP (1999) Proc Natl Acad Sci U S A 96: 5203-8 Cardiac-enriched LIM domain protein fhl2 is required to generate I(Ks) in a heterologous system. Kupershmidt S, Yang IC, Sutherland M, Wells KS, Yang T, Yang P, Balser JR, Roden DM (2002) Cardiovasc Res 56: 93-103 A structural requirement for processing the cardiac K+ channel KCNQ1. Kanki H, Kupershmidt S, Yang T, Wells S, Roden DM (2004) J Biol Chem 279: 33976-83 Stereoselective interactions of the enantiomers of chromanol 293B with human voltage-gated potassium channels. Yang IC, Scherz MW, Bahinski A, Bennett PB, Murray KT (2000) J Pharmacol Exp Ther 294: 955-62
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.